Netcall (NET) Competitors

Netcall (LON:NET) and Dr. Martens (LON:DOCS) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

Does the media prefer NET or DOCS?

In the previous week, Netcall had 2 more articles in the media than Dr. Martens. MarketBeat recorded 5 mentions for Netcall and 3 mentions for Dr. Martens. Dr. Martens' average media sentiment score of 1.51 beat Netcall's score of 0.43 indicating that Dr. Martens is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Netcall	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Dr. Martens	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do analysts recommend NET or DOCS?

Netcall currently has a consensus target price of GBX 130, suggesting a potential upside of 26.68%. Given Netcall's stronger consensus rating and higher probable upside, research analysts plainly believe Netcall is more favorable than Dr. Martens.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Netcall	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Dr. Martens	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the MarketBeat Community believe in NET or DOCS?

Netcall received 151 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 91.67% of users gave Dr. Martens an outperform vote while only 58.06% of users gave Netcall an outperform vote.

Company	Underperform	Outperform
Netcall	Outperform Votes 162 58.06%	Underperform Votes 117 41.94%
Dr. Martens	Outperform Votes 11 91.67%	Underperform Votes 1 8.33%

Which has higher valuation & earnings, NET or DOCS?

Dr. Martens has higher revenue and earnings than Netcall. Dr. Martens is trading at a lower price-to-earnings ratio than Netcall, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Netcall	£37.42M	4.52	£5.36M	£0.03	3,420.67
Dr. Martens	£877.10M	0.77	£69.20M	£0.07	999.61

Is NET or DOCS a better dividend stock?

Netcall pays an annual dividend of GBX 1 per share and has a dividend yield of 1.0%. Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 4.3%. Netcall pays out 3,333.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Dr. Martens pays out 4,285.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Do insiders and institutionals have more ownership in NET or DOCS?

69.3% of Netcall shares are owned by institutional investors. Comparatively, 69.5% of Dr. Martens shares are owned by institutional investors. 11.5% of Netcall shares are owned by insiders. Comparatively, 4.4% of Dr. Martens shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is NET or DOCS more profitable?

Netcall has a net margin of 14.32% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 17.92% beat Netcall's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Netcall	14.32%	15.24%	4.62%
Dr. Martens	7.89%	17.92%	8.12%

Which has more volatility & risk, NET or DOCS?

Netcall has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, Dr. Martens has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500.

Summary

Netcall beats Dr. Martens on 11 of the 20 factors compared between the two stocks.